Faricimab FDA approval: Dr. Joshua Mali shares what this new therapy will mean to retina specialists
January 29, 2022
Joshua Mali, MD, shares how the FDA-approved faricimab-svoa (Vabysmo, Genentech) will change the treatment landscape for wet AMD and DME.